-
1
-
-
3142583579
-
Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporine A-treated patients
-
Buduneli N, Buduneli E, Cinar S, Atilla G, Lappin D, Kinane D (2004. Plasminogen activators and plasminogen activator inhibitors in gingival crevicular fluid of cyclosporine A-treated patients. J Clin Periodontol 31: 556-561.
-
(2004)
J Clin Periodontol
, vol.31
, pp. 556-561
-
-
Buduneli, N.1
Buduneli, E.2
Cinar, S.3
Atilla, G.4
Lappin, D.5
Kinane, D.6
-
2
-
-
0032005256
-
Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro
-
Chang YC, Tai KW, Cheng MH, Chou LSS, Chou MY (1998. Cytotoxic and non-genotoxic effects of arecoline on human buccal fibroblasts in vitro. J Oral Pathol Med 27: 68-71.
-
(1998)
J Oral Pathol Med
, vol.27
, pp. 68-71
-
-
Chang, Y.C.1
Tai, K.W.2
Cheng, M.H.3
Chou, L.S.S.4
Chou, M.Y.5
-
3
-
-
0034694785
-
Synergistic effects of peroxynitrite on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts
-
Chang YC, Tai KW, Chou MY, Tseng TH (2000. Synergistic effects of peroxynitrite on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. Toxicol Lett 118: 61-68.
-
(2000)
Toxicol Lett
, vol.118
, pp. 61-68
-
-
Chang, Y.C.1
Tai, K.W.2
Chou, M.Y.3
Tseng, T.H.4
-
4
-
-
0034879232
-
Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts
-
Chang YC, Hu CC, Tseng TH, Tai KW, Lii CK, Chou MY (2001. Synergistic effects of nicotine on arecoline-induced cytotoxicity in human buccal mucosal fibroblasts. J Oral Pathol Med 130: 458-464.
-
(2001)
J Oral Pathol Med
, vol.130
, pp. 458-464
-
-
Chang, Y.C.1
Hu, C.C.2
Tseng, T.H.3
Tai, K.W.4
Lii, C.K.5
Chou, M.Y.6
-
5
-
-
0036178708
-
Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis
-
Chang YC, Yang SF, Tai KW, Chou MY, Hsieh YS (2002a). Increased tissue inhibitor of metalloproteinase-1 expression and inhibition of gelatinase A activity in buccal mucosal fibroblasts by arecoline as possible mechanisms for oral submucous fibrosis. Oral Oncol 38: 195-200.
-
(2002)
Oral Oncol
, vol.38
, pp. 195-200
-
-
Chang, Y.C.1
Yang, S.F.2
Tai, K.W.3
Chou, M.Y.4
Hsieh, Y.S.5
-
6
-
-
0036317726
-
Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis
-
Chang YC, Tsai CH, Tai KW, Yang SH, Chou MY, Lii CK (2002b. Elevated vimentin expression in buccal mucosal fibroblasts by arecoline in vitro as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 38: 425-430.
-
(2002)
Oral Oncol
, vol.38
, pp. 425-430
-
-
Chang, Y.C.1
Tsai, C.H.2
Tai, K.W.3
Yang, S.H.4
Chou, M.Y.5
Lii, C.K.6
-
7
-
-
0022615750
-
Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids
-
Harvey W, Scutt A, Meghji S, Canniff JP (1986. Stimulation of human buccal mucosa fibroblasts in vitro by betel-nut alkaloids. Arch Oral Biol 31: 45-49.
-
(1986)
Arch Oral Biol
, vol.31
, pp. 45-49
-
-
Harvey, W.1
Scutt, A.2
Meghji, S.3
Canniff, J.P.4
-
8
-
-
0028787122
-
Biological and clinical aspects of plasminogen activator type 2
-
Kruithof EKO, Baker MS, Bunn CL (1995. Biological and clinical aspects of plasminogen activator type 2. Blood 86: 4007-4024.
-
(1995)
Blood
, vol.86
, pp. 4007-4024
-
-
Kruithof, E.K.O.1
Baker, M.S.2
Bunn, C.L.3
-
9
-
-
0029401138
-
Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures
-
Kuo MYP, Chen HM, Hahn LJ, Hsieh CC, Chiang CP (1995). Collagen biosynthesis in human oral submucous fibrosis fibroblast cultures. J Dent Res 74: 1783-1788.
-
(1995)
J Dent Res
, vol.74
, pp. 1783-1788
-
-
Kuo, M.Y.P.1
Chen, H.M.2
Hahn, L.J.3
Hsieh, C.C.4
Chiang, C.P.5
-
10
-
-
0029382417
-
Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan
-
Ma RH, Tsai CC, Shieh TY (1995. Increased lysyl oxidase activity in fibroblasts cultured from oral submucous fibrosis associated with betel nut chewing in Taiwan. J Oral Pathol Med 24: 407-412.
-
(1995)
J Oral Pathol Med
, vol.24
, pp. 407-412
-
-
Ma, R.H.1
Tsai, C.C.2
Shieh, T.Y.3
-
11
-
-
0028380990
-
Role of areca nut in the causation of oral submucous fibrosis: A case-control study in Pakistan
-
Maber R, Lee AJ, Warnakulasuriya KAAS, Lewis JA, Johnson NW (1994. Role of areca nut in the causation of oral submucous fibrosis: a case-control study in Pakistan. J Oral Pathol Med 23: 65-69.
-
(1994)
J Oral Pathol Med
, vol.23
, pp. 65-69
-
-
Maber, R.1
Lee, A.J.2
Warnakulasuriya, K.A.A.S.3
Lewis, J.A.4
Johnson, N.W.5
-
12
-
-
84985822387
-
Oral submucous fibrosis as a precancerous condition
-
Pindorg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS (1984. Oral submucous fibrosis as a precancerous condition. Scand J Dent Res 92: 224-229.
-
(1984)
Scand J Dent Res
, vol.92
, pp. 224-229
-
-
Pindorg, J.J.1
Murti, P.R.2
Bhonsle, R.B.3
Gupta, P.C.4
Daftary, D.K.5
Mehta, F.S.6
-
13
-
-
0002498907
-
The renal plasminogen activity system
-
Schlondorff D, Bonventre JV, eds, Marcel Dekker Inc, New York, pp
-
Rondeau E, Sraer JD, Schleuning WD (1995. The renal plasminogen activity system. In: Schlondorff D, Bonventre JV, eds. Molecular nephrology: kidney function in health and diseased. Marcel Dekker Inc.: New York, pp. 699-715.
-
(1995)
Molecular nephrology: Kidney function in health and diseased
, pp. 699-715
-
-
Rondeau, E.1
Sraer, J.D.2
Schleuning, W.D.3
-
14
-
-
0025307521
-
A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut
-
Sinor PN, Gupta PC, Murti PR et al (1990. A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med 19: 94-98.
-
(1990)
J Oral Pathol Med
, vol.19
, pp. 94-98
-
-
Sinor, P.N.1
Gupta, P.C.2
Murti, P.R.3
-
15
-
-
0030136756
-
Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix
-
Stetler-Stevenson WG (1996. Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 148: 1345-1350.
-
(1996)
Am J Pathol
, vol.148
, pp. 1345-1350
-
-
Stetler-Stevenson, W.G.1
-
16
-
-
0033169008
-
The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma
-
Trivedy C, Warnakulasuriya KAAS, Hazarey VK, Tavassoli M, Sommer P, Johnson NW (1999. The upregulation of lysyl oxidase in oral submucous fibrosis and squamous cell carcinoma. J Oral Pathol Med 28: 246-251.
-
(1999)
J Oral Pathol Med
, vol.28
, pp. 246-251
-
-
Trivedy, C.1
Warnakulasuriya, K.A.A.S.2
Hazarey, V.K.3
Tavassoli, M.4
Sommer, P.5
Johnson, N.W.6
-
17
-
-
0038624020
-
The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: A possible role in the pathogenesis of oral submucous fibrosis
-
Tsai CH, Chou MY, Chang YC (2003. The upregulation of cyclooxygenase-2 expression in human buccal mucosal fibroblasts by arecoline: a possible role in the pathogenesis of oral submucous fibrosis. J Oral Pathol Med 32: 146-153.
-
(2003)
J Oral Pathol Med
, vol.32
, pp. 146-153
-
-
Tsai, C.H.1
Chou, M.Y.2
Chang, Y.C.3
-
19
-
-
0036854980
-
Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy
-
Yang J, Shultz RW, Mars WM et al (2002. Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy. J Clin Invest 110: 1525-1538.
-
(2002)
J Clin Invest
, vol.110
, pp. 1525-1538
-
-
Yang, J.1
Shultz, R.W.2
Mars, W.M.3
-
20
-
-
0037409334
-
The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis
-
Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC (2003). The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 39: 367-372.
-
(2003)
Oral Oncol
, vol.39
, pp. 367-372
-
-
Yang, S.F.1
Hsieh, Y.S.2
Tsai, C.H.3
Chou, M.Y.4
Chang, Y.C.5
|